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Background: Acetylcholinesterase (AChE) inhibitors or anticholinesterases reduce the activity of enzyme
acetylcholinesterase that degrades the neurotransmitter acetylcholine in the brain. The inhibitors have a significant
pharmacological role in neurodegenerative diseases like Alzheimer’s and Parkinson’s etc. Although plants have been
a significant source of these compounds, there are very few sporadic reports of microorganisms producing such
inhibitors. Anticholinesterase activity in bacterial associates of marine soft corals and sponges were not previously
reported.
Results: We screened 887 marine bacteria for the presence of acetylcholinesterase inhibitors, in a microplate based
assay, and found that 140 (15.8%) of them inhibit the electric eel enzyme, acetylcholinesterase. Majority of the active
isolates were bacterial associates of soft corals followed by sediment isolates while most of the potent inhibitors
belonged to the bacterial associates of marine sponges. Maximum inhibition (54%) was exhibited by a bacterial
strain M18SP4P (ii), isolated from the marine sponge Fasciospongia cavernosa. Based on phenotypic characterization
and 16S rDNA sequencing, the strain was identified as Bacillus subtilis - revealing yet another activity in a strain of
the model organism that is considered to be a cell factory. TLC bioautography of the methanol extract of this
culture, showed the presence of two major components having this activity, when compared to Galanthamine, the
positive control.
Conclusion: From the results of our study, we conclude that acetylcholinesterase inhibitors are quite prevalent in
marine bacteria, particularly the bacterial associates of marine invertebrates. Several potential AChE inhibitors in
marine bacteria are waiting to be discovered to provide easily manipulable natural sources for the mass production
of these therapeutic compounds.
Keywords: Acetylcholinesterase inhibitors, Galanthamine, Alzheimer’s disease, Fasciospongia cavernosa, Marine
bacteria, Screening, Soft coral, marine sedimentIntroduction
Acetylcholinesterase inhibitors (AChEIs) work by increas-
ing the concentration of acetylcholine (ACh) in the brain,
due to reduction in the rate of its breakdown by acetyl-
cholinesterase (AChE). These inhibitors, naturally found
in venoms, have a range of applications from pharmaceu-
ticals to insecticides and weapons like nerve gas [1]. An* Correspondence: sony@immt.res.in
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unless otherwise stated.important therapeutic use of AChE inhibitors is in the
treatment of dementia associated with Alzheimer’s disease.
There is no cure yet for this disease; four out of five FDA
approved drugs are AChE inhibitors, which provide symp-
tomatic relief, by improving signal transfer in the brain
and slowing down the neurofibrillary degeneration [2].
However, the importance of acetylcholinesterase inhibitors
cannot be underestimated because recent research shows
that these inhibitors protect brain cells against free radical
injury and β-amyloid toxicity in Alzheimer’s disease (AD)
[3]. Despite the quest for new treatments to stop, slow orLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for new sources of AChE inhibitors also, because of
the concerns around the bioavailability and side-effects
issues, associated with the existing, mostly synthetic, drugs
for AD.
The natural sources are favoured for screening AChE
inhibitors since they present enormous possibilities of
discovering novel chemical structures with better prop-
erties. Majority of AChE inhibitors are derived from
plants [1,4], but they were also isolated from extracts of
some algae, fungi, cyanobacteria, marine phytoplankton
and marine sessile organisms like sponges and soft corals.
For example, anticholinesterase compounds like the arisu-
gacin, sporothrin and curvularin have been isolated from
fungi [5-7]; sargaquinoic acid was found in marine alga
Sargassum sagamianum [8] and recently, biruloquinone
isolated from a lichen forming fungi Cladonia macilenta,
was identified as an inhibitor of acetylcholinesterase [9].
Very few AChE inhibitor compounds have been isolated
from the bacterial sources. AChEI activity in bacteria was
first reported in Streptomyces antibioticus, when two related
furo-dioxa-phosphepin organophosphorus compounds,
used in pesticides, were isolated from its cultures [10]. Sub-
sequently, another AChE inhibitor, cyclophostin was found
in Strepomyces lavendulae [11]. In the recent past, mari-
noquinoline A (a new alkaloid possessing pyrroloquino-
line skeleton) was isolated from a marine gliding
bacterium Rapidithrix thailandica (phylum Bacteroidetes).
The AChE inhibitory activity of marinoquinoline A was
discovered, after the compound was found to be structur-
ally related to tacrine, which is an AChE inhibitor [12].
Marinoquinoline A was again isolated from another novel
marine Bacteroidetes member Ohtaekwangia kribbensis
[13]; hence this organism may, as well, inhibit AChE.
The latest discoveries about marinoquinoline A, coupled
with, the reports claiming novel inhibitors from chemicalTable 1 AChE inhibition activity in marine isolates
Sl. no. Isolation source No. of isolates
screened
No. of
1. Acanthella cavernosa 39 9
2. Dragmacidon agariciforme 110 17
3. Fasciospongia cavernosa 8 2
4. Leiodermatium pfeifferae 72 7
5. Rhabdastrella globostellata 127 18
6. Siphonodictyon coralliphagum 31 13
7. Xestospongia testudinaria 36 5
8. Sarcotragus fasciculatus 77 0
9. Soft coral 66 16
10. Sediment 321 53
Total 887 140investigations of marine sessile organisms [14-16], strongly
indicate the potential of bacteria as a source of these im-
portant compounds from marine samples. Considering
the enormous diversity of marine microorganisms, we set
out to find the prevalence of acetylcholinesterase inhibi-
tors in marine bacteria isolated from different samples of
marine sponges, soft corals and sediments, using a high
throughput microplate based assay. In this research report,
we present an interesting finding that uncovers another
activity - AChE inhibition - of a robust microorganism,
amenable to manipulation and biotechnological scale-up
for the production process.Results
Screening assay
Out of the 887 isolates tested for AChE inhibition activ-
ity, 140 isolates were found to be positive (Table 1; de-
tails in Additional file 1: Table S1). The proportion of
positives hits was more in soft corals (n = 16 out of 66)
followed by sediment (n = 53 out of 321) and sponges
(n = 71 out of 500) as shown in Figure 1. The positive con-
trol, 0.1 μM galanthamine, inhibited 74% AChE while at
higher concentrations, it showed 100% inhibition. Figure 2
shows a comparison of AChE inhibition activity of the eight
sponge isolates taken in this study. Among the sponge sam-
ples Siphonodictyon coralliphagum isolates were the most
active and potent inhibitors, followed by Fasciospongia cav-
ernosa, Acanthella cavernosa, Dragmacidon agariciforme,
Rhabdastrella globostellata, Xestospongia testudinaria
and Leiodermatium pfeifferae; however, none of the 77
isolates of Sarcotragus fasciculatus were active. The sponge
isolates have a comparatively large number of potent
inhibitors, i.e, they showed higher percentages of inhib-
ition (Additional file 1: Table S1). An isolate of the




















Soft corals Sponges Sediment
Figure 1 The distribution of AChEI positive isolates among soft
corals, sponges and sediment.
Pandey et al. Microbial Cell Factories 2014, 13:24 Page 3 of 9
http://www.microbialcellfactories.com/content/13/1/24showed the maximum percentage (54%) of AChE
inhibition.
Identification of M18SP4Q (ii)
The bacterial strain M18SP4Q (ii) was Gram positive
slender rod with the spore in non-bulging sporangia.
The strain was aerobic, grew in the presence of 6.5%
NaCl and tested positive for starch, VP and Citrate; de-
tails are available in Table 2. The 16S rDNA sequence
(GenBank accession number KC886741) of this strain
showed 99.86% similarity with the type strain of Bacillus
subtilis subsp. subtilis. The phenotypic characters com-
bined with 16S rRNA gene sequence confirmed the identity
of the strain as Bacillus subtilis. The evolutionary relation-
ship of this strain M18SP4Q (ii), with the 16S rRNA gene
sequences of its closely related strains is shown in the
Neighbor-Joining phylogenetic tree (Figure 3).
TLC bioautography of M18SP4Q (ii)
TLC bioautography, performed to analyze the inhibitor





























AChE inhibition activity a
Figure 2 Comparison of AChE inhibition activity among sponge isolacode IMM 46), showed the presence of two major com-
pounds at Rf – 0.45 and 0.85 in IMM46, while the
galanthamine spot was observed at Rf – 0.58; indicating
that the compounds are chemically different from ga-
lanthamine (Figure 4).
Discussion
Many prominent researchers have reviewed the literature
on marine natural products and unequivocally hailed
the bioactive potential of marine microbes. Some of
them proposed and demonstrated that marine inverte-
brate associated microbes are the primary producers of
biologically active metabolites and play an important
role in the host defense [20,21]. Nonetheless, very few
studies have identified the microbial producers of sponge-
associated compounds; on the other hand, few microor-
ganisms of the diverse microbial community associated
with the sponges have a known function. Although bridg-
ing this gap is not so easy for a single research group, we
initiated a basic search for a function, i.e., acetylcholin-
esterase inhibition, in the diverse microbial associates of
sponges, sediment and soft corals. This research report is
the first account of AChE inhibition activity in the micro-
bial associates of the marine invertebrates and sediment.
Screening results analysis
Our findings showed a significant number, constituting
16%, of the isolates screened in this study with AChE
inhibition activity. The major share of the positive cul-
tures comes from soft corals followed by the sediment
and sponge samples (Figure 1). Literature reviews of
natural product AChE inhibitors shows that the majority
of AChEIs are alkaloids followed by mono-, di-, tri- and
sesqui-terpenes; while a few flavonoids, coumarins and
other compounds are also on the list [22]. Soft corals are
known to produce different types of terpenes; as a recent
example, Bonnard et al. [14] discovered novel bioactive
natural terpenes upon chemical investigations of co-
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pH requirement 6-8
Growth at 6.5% NaCl +
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source of terpene derivatives; like, the dinoflagellate
Symbiodinium sp. was identified as a producer of pseu-
dopterosins, the pharmacologically important diterpene
glycosides, in a gorgonian soft coral [23]. Although
these findings are not connected, it is apparent that the
AChE inhibiting terpenes have been found in different
soft coral extracts, and coral microbial symbionts too
have been shown to produce a class of terpenes. A very
recent study, using the new technique of “genome min-
ing” [24], also reveals tremendous biosynthetic potential
of several bacterial species for terpene synthesis. Hence,
it may be assumed that the terpenes isolated from dif-
ferent soft coral may have originated in the associated
microbes.
Other chemical compounds from invertebrate extracts
may show similar links if studied in depth because litera-
ture is replete with reports which show the involvement of
different chemical classes of compounds in many of the
biological activities. If such different classes of compoundscan show the same activity, the chances of these com-
pounds being found in the microbial world are not sur-
prising. It has been observed in chemical investigations of
natural extracts that the novel compounds are mostly vari-
ants or derivatives of existing major chemical classes of
compounds. So, the general opinion of microbes being the
primary producers of sponge or coral metabolites may
gather more proofs with the concerted efforts of marine
microbiologists and natural product chemists. This also
explains why such large numbers of marine isolates exhib-
ited AChEI activity.
AChEIs in sponge microbes
An examination of Table 1 shows that the maximum num-
ber of active isolates belong to the sponge Siphonodictyon
coralliphagum, exhibiting consistently higher percentages
of inhibition as compared to all other isolates. Earlier, a
number of new meroterpenoid and spirosesquiterpene al-
dehyde compounds, like corallidictyals and liphagal; sipho-
nodictyal sulfate and akadisulfates, have been isolated from
the extracts of the sponge Siphonodictyon coralliphagum
(= Aka coralliphaga); which showed protein kinase C in-
hibition, PI3K inhibitory activity and radical-scavenging
activity respectively [25-27]. Some siphonodictyals and
corallidictyals have also been reported to have antimicro-
bial activity [28,29]. The other sponges from which com-
pounds with antimicrobial activity have been isolated are
Fasciospongia cavernosa [30] and Acanthella cavernosa
[31-33]. A careful study of the previous literature showed
that several compounds with AChEI activity, isolated from
the sponges, mostly derivatives of alkaloids and terpenes
[22]. However, anticholinesterase activity of the com-
pounds of the above mentioned sponges or their microbial
associates was not known so far, which may be due to
limited research in this area. Recently, a web resource -
DESMSCI – was developed for knowledge generation
on marine sponge compounds interactions including a
useful “hypothesis generation” feature [34]. Using this
web resource, the authors could generate and theoretically
validate a hypothesis, by linking terms from different dic-
tionaries. According to this hypothesis there is a possibility
of finding a novel mode of action for a sponge compound
variolin (an alkaloid) in AD. Thus, it is apparent that
sponge compounds, like alkaloids, may not just inhibit
AChE to provide symptomatic relief in AD, but may even
have a disease modifying effect which needs to be studied
in depth.
AChEI in Bacillus subtilis
The isolate M18SP4Q (ii), which showed the maximum
percentage of AChE inhibition in the present screening,
was taxonomically identified as Bacillus subtilis. This
omnipresent saprophytic bacterium can survive in ex-
treme conditions and is ecologically important due to its
B. siamensis
B. amyloliquefaciens subsp. plantarum 
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Figure 3 The evolutionary relationship of the strain M18SP4Q (ii) with the 16S rRNA gene sequences of its closely related strains is
shown in the neighbour joining phylogenetic tree. The evolutionary history was inferred using the Neighbor-Joining method [17]. The optimal
tree with the sum of branch length = 0.33445952 is shown. The percentage of replicate trees in which the associated taxa clustered together in
the bootstrap test (1000 replicates) is shown above the branches [18]. The tree is drawn to scale, with branch lengths in the same units as those
of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the p-distance method [19]
and are in the units of the number of base differences per site. The analysis involved 28 nucleotide sequences. All ambiguous positions were
removed for each sequence pair. There were a total of 1539 positions in the final dataset.
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they play varied role from nutrient recycling to heavy
metal accumulation or detoxification. Besides enzymes,
they also produce antibiotics and their biosurfactant
lipopeptides, called surfactins, have been reported to
have mosquito larvicidal and pupicidal activity [35-37].
It is also commercially used in the production of amyl-
ase, protease, lipase, amino acids, inosine, ribosides, hya-
luronic acid and polyhydroxybutarate. Bacillus subtilis is
a favorable workhorse for the biotechnology industry be-
cause it is highly responsive to genetic manipulation. Re-
cently, van Dijl and Hecker [38] suggested that Bacillus
subtilis can be engineered into next-generation super-secreting cell factory using combined systems and syn-
thetic biology approach. Thus, the detection of acetyl-
cholinesterase inhibition in a Bacillus subtilis strain is
certainly a significant finding.
Diversity of bacteria with AChEI activity
Microbes producing AChE inhibitors are few and far
between in the past literature. In our taxonomic inves-
tigation of some marine bacteria, we found several dif-
ferent genera of bacteria produce AChE inhibitors, like,
Psychrobacter, Microbacterium, Stenotrophomonas, Plano-
coccus, Nocardia, Streptomyces sp., Leucobacter, Bacillus
sp., Virgibacillus and Brevibacterium sp. (Additional file 2:
12
C
Figure 4 TLC bioautography of IMM46 extract showing two
compounds 1 & 2 containing the inhibitor of acetylcholinesterase,
and C - control (0.1 μM Galanthamine).
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ment of diverse groups of microorganisms in AChE inhibi-
tor production increases the chances of finding structurally
unique metabolites. Recently, phylogenetically diverse urea
utilizing microbes associated with the sponge Xestospongia
testudinaria was reported, and our group has also reported
a diverse marine microbial community producing beta-
glucosidase inhibitors [39,40]. The research on marine bac-
teria has not been extensive; therefore, the bioactive strains
isolated from marine samples may present themselves as
new to natural products research. Thus, the efforts to
screen natural products from marine bacteria for industri-
ally important activities are desirable conjointly with the
molecular techniques in the metagenomic era.
Conclusion
Acetylcholinesterase inhibitors in bacteria have not re-
ceived adequate attention of the researchers. Our as-
sumption on the preponderance of AChEIs in marinebacteria proved to be correct. The AChEI activity has
been detected in good numbers, in the microbial associates
of soft corals, sponges and sediments. Bacillus subtilis - a
well studied and exploited species - presented yet another
activity, though it remains to be seen whether the com-
pound responsible for this activity is new or known. These
results imply that many anticholinesterase compounds are
waiting to be discovered in marine bacteria of different lin-
eages. Chemical investigation of hits from this study may
be pursued in order to use these compounds. In future,
the marine microbial secondary metabolites may be con-
sidered for further studies in the development of drugs for
the treatment of AD because the present work shows a




AChE Type VI-S, EC 3.1.1.7, from electric eel (Electroph-
orus electricus) and galanthamine hydrobromide from
Lycoris sp. were purchased from Sigma (St. Louis, MO,
USA). Acetylthiocholine iodide (ATCI), 5,5’-dithiobis-(2-
nitrobenzoic acid) (DTNB), bovine serum albumin (BSA),
dimethylsulfoxide (DMSO), Tris–HCl and microbiological
media were procured from HiMedia Laboratories Pvt.
Ltd., Mumbai, India. The chemicals used in the study were
of the highest purity and used without further purification.
Buffers and reagents
A stock solution of 1.17 mg/ml acetylcholinesterase
(425.94 U/mg) was prepared with 0.1% BSA in buffer A
(50 mM Tris–HCl, pH-8) and stored in −20°C, and work-
ing solutions of 0.01 U/ml and 3 U/ml were prepared by
dilution. Phosphate buffer (pH 7.5), 1.5 mM ATCI recon-
stituted in phosphate buffer and 3 mM DTNB in phos-
phate buffer. Galanthamine 5 mg/ml was dissolved in
methanol and further diluted in phosphate buffer to make
a working stock of 0.1 μM ml-1.
Bacterial strains and culture conditions
A large number of marine microorganisms were isolated
from the samples of marine sponges, soft corals and sedi-
ment, collected from the Bay of Bengal on the east coast
of India. The initial isolations were carried out on a variety
of media prepared in seawater at temperatures ranging
from 20-30°C. Many of these isolates were screened for
the investigation of the presence of acetylcholinesterase
inhibitors in the associates of marine sponges, soft corals
and sediment samples. In this study, a total of 887 marine
microorganisms isolated from samples of 8 sponges [total
n = 500; Rhabdastrella globostella (n = 127), Acanthella
cavernosa (n = 39), Dragmacidon agariciforme (n = 110),
Leiodermatium pfeifferae (n = 72), Fasciospongia cavernosa
(n = 08), Xestospongia testudinaria (n = 36), Siphonodictyon
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(n = 77)], 2 unidentified soft corals (n = 66) and 5 sedi-
ments (n = 321) were investigated. All these organisms
grew on Nutrient Agar media (HiMedia, Mumbai) pre-
pared in 50% aged natural seawater at 30°C within 48–
72 hrs.
Extraction of metabolites
The microbial metabolites were extracted as described
in Pandey et al. [40]. Briefly, the cultures were grown in
50 ml of Nutrient Broth with 50% seawater, at 30°C/48 hrs
and 200 rpm in a rotary shaker, followed by centrifugation
at 9000 rpm/20 min to remove the cell mass. The super-
natant was mixed with 10% Diaion HP-20 (Sigma) resin
for 30 min on a magnetic stirrer. Then the Diaion resin
along with supernatant was packed in a glass column,
washed with 15 ml distilled water, and eluted with 20 ml
methanol. The collected methanol was evaporated, and
the extract was dissolved in DMSO.
AChE inhibition assay
AChE inhibitory activity was tested using a microplate
assay based on the modified method of Ellman et al.
[41]. The enzyme hydrolyzed the substrate acetylthio-
choline resulting in the product thiocholine which reacts
with Ellman’s reagent (DTNB) in situ and gives the yel-
low coloured chromophore of 5-thio-2-nitrobenzoic acid
(TNB), which can be detected at 405 nm. The absorp-
tion intensity of TNB adduct (405 nm) is proportional to
the formation of thiocholine, therefore, the AChE activ-
ity. In each well of the 96-well microtiter plate, 5 μl of
microbial extract and 10 μl of 0.01 U ml-1 of acetylcho-
line esterase were incubated at 4°C for 20 min before the
addition of 10 μl of 1.5 mM ATCI in phosphate buffer
(pH 7.5), 60 μl of 3 mM DTNB in phosphate buffer
(pH 7.5), 60 μl of 0.1 M phosphate buffer (pH 7.5) and
absorbance was measured at 405 nm every 30 s for
4 min × 8 times on a TRIAD multimode reader (Dynex
Technologies, Inc., Chantilly, VA). The rate of reactions
was calculated using the Manager software of the multi-
mode reader. Percentage of inhibition was calculated by
comparing the rates for each sample with respect to the
blank (10% DMSO in buffer). Galanthamine hydrobro-
mide (0.1 μM ml-1) in DMSO solvent was used as a
positive control. Each assay was performed in triplicate,
and the AChE inhibitory values are the average of three
independent experiments. The percent inhibition was
calculated using the following equation:
% Inhibition ¼ Acontrol–Asample
Acontrol
 100
where Asample was the absorbance of the sample micro-
bial extract, and Acontrol was the absorbance of theblank reaction mixture without the inhibitor - negative
control.
TLC bioautography
TLC bioautographic assay was carried out for the crude
extract (IMM46), from the isolate M18SP4Q (ii) that
showed the highest inhibition of AChE, as described by
Rhee et al. [42], but with some modifications in the re-
agent concentrations. The substrate ATCI and chromogen
DTNB was prepared as 2 mM solutions in 10 ml of buffer
A. TLC assay was done on Silicagel 60 F 254 nm plates of
0.2 mm thickness with 1 μL each of M18SP4Q (ii) extract
(100 mg/ml) and 1 μL of 0.1 μM ml-1 galanthamine spot-
ted on the plate, developed in chloroform:methanol (8:2)
in the mobile phase. After the TLC plate was developed,
equal volume of 2 mM solutions of ATCI and DTNB was
sprayed on the TLC plate until the plate was saturated.
The plate was air dried for 5 min and then the enzyme -
10 ml of 3 U/ml AChE enzyme solution - was sprayed on
the TLC plate. Yellow colour appeared within 5–10 min
on the TLC plate except in places where the inhibitor was
present.
Microbial identification
The isolate, M18SP4Q (ii), was identified by partial 16S
rRNA gene sequencing and phenotypic characterization
[43]. The colony and cell morphology, including spores,
were characterized, and starch, nitrate, VP and NaCl tol-
erance tests were performed as described by Claus and
Berkeley [44]. The 16S rRNA gene based identification
was done as described in Pandey et al. (36). Briefly, a
25 μl PCR reaction was set up with 10 pmol primers –
27 F and 1492R, 150 ng DNA, 5 mM dNTPs, 1× Taq
polymerase buffer containing 15 mM MgCl2 and 0.5 μl
of Taq DNA polymerase (5 U/μl, Fermentas) as per the
programme: 94°C for 5 min, 30 cycles of 94°C for 1 min,
50°C for 1 min, 72°C for 2 min and 72°C for 10 min.
The PCR product was separated on 1% agarose gel, and
the DNA fragments were extracted. The purified 16S
rDNA was sequenced in Beckman Coulter Ceq 8000
genetic analysis system. The sequence thus obtained was
deposited in GenBank and aligned with the other sequences
using BLAST program in NCBI (http://blast.ncbi.nlm.nih.
gov). The EzTaxon server 2.1 (http://eztaxon-e.ezbiocloud.
net/) was also used to obtain the closest matching type
strain sequences from the database. The identity of the
strain was established based on the phenotypic characters
and sequence identity.
Phylogenetic analysis
The 16S rDNA sequences of the closest relatives (type
strains) of the strain M18SP4Q (ii) were retrieved from
EzTaxon, and multiple sequence alignment was performed
using Clustal_X program [45]. The evolutionary relatedness
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method, distance calculated using the p-distance method,
followed by bootstrap test in 1000 replicates for each clus-
ter and the phylogenetic tree was drawn in MEGA5.0 pro-
gram available at http://www.megasoftware.net/ [46].
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